Achaogen
  • Company Overview Our Culture Management Team Board of Directors Scientific Advisory Board
  • Overview MDR Gram-Negative Infections Our Science
  • Pipeline Overview Plazomicin C-Scape Monoclonal Antibody Program Additional Gram-Negative Programs Scientific Publications
  • Investor Overview Press Releases Events & Presentations Corporate Governance Financials & Filings Stock Information Contact Us
  • Overview Values Benefits Positions Available Postdoctoral Program Fellowship
  • Contact Information Medical Information
Achaogen
  • About Us/
    • Company Overview
    • Our Culture
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
  • Our Focus/
    • Overview
    • MDR Gram-Negative Infections
    • Our Science
  • Pipeline/
    • Pipeline Overview
    • Plazomicin
    • C-Scape
    • Monoclonal Antibody Program
    • Additional Gram-Negative Programs
    • Scientific Publications
  • Investors/
    • Investor Overview
    • Press Releases
    • Events & Presentations
    • Corporate Governance
    • Financials & Filings
    • Stock Information
    • Contact Us
  • Careers/
    • Overview
    • Values
    • Benefits
    • Positions Available
    • Postdoctoral Program
    • Fellowship
  • Contact Us/
    • Contact Information
    • Medical Information
  • /
Proteus v3 (low res).jpg
Achaogen

Media

Achaogen
  • About Us/
    • Company Overview
    • Our Culture
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
  • Our Focus/
    • Overview
    • MDR Gram-Negative Infections
    • Our Science
  • Pipeline/
    • Pipeline Overview
    • Plazomicin
    • C-Scape
    • Monoclonal Antibody Program
    • Additional Gram-Negative Programs
    • Scientific Publications
  • Investors/
    • Investor Overview
    • Press Releases
    • Events & Presentations
    • Corporate Governance
    • Financials & Filings
    • Stock Information
    • Contact Us
  • Careers/
    • Overview
    • Values
    • Benefits
    • Positions Available
    • Postdoctoral Program
    • Fellowship
  • Contact Us/
    • Contact Information
    • Medical Information
  • /
May 01, 2011

Activity of ACHN-490 Tested Alone and in Combination with Other Agents against Pseudomonas aeruginosa

May 01, 2011/ Ian C. Olson

Pankuch GA, Lin G, Kubo A, Armstrong ES, Appelbaum PC, Kosowska-Shick K.
Antimicrobial Agents and Chemotherapy, May 2011,p. 2463-2465, Vol. 55, No. 5

Access this publication @ aac.asm.org
May 01, 2011/ Ian C. Olson/
Scientific Publications
2011, Plazomicin 2011, Plazomicin

Ian C. Olson

  • Activity of ACHN-490 against MDR ...
  • Achaogen Appoints Kenneth J. ...

© Achaogen, Inc. 2004-present. All rights reserved.     Privacy Policy | Terms of Use